Assignee
DELINIA INC
US·9 granted patents·10 pending applications·81 citations·filing 2015–2021
Top patents by PatentIndex Score
19 records- 0198US10035836B1Modified IL-2 variants that selectively activate regulatory T cellsDELINIA INC·Filed 2015·Granted Jul 31, 2018·47 cites·5 claims
- 0297US10294287B2Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2017·Granted May 21, 2019·22 cites·13 claims
- 0395US10774126B2Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2019·Granted Sep 15, 2020·4 cites·9 claims
- 0491US10766938B2Nucleic acid encoding human IL-2 variantDELINIA INC·Filed 2019·Granted Sep 8, 2020·2 cites·13 claims
- 0585US10472405B2Multivalent regulatory T cell modulatorsDELINIA INC·Filed 2017·Granted Nov 12, 2019·3 cites·13 claims
- 0681US10875901B2Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2019·Granted Dec 29, 2020·1 cites·13 claims
- 0780US11535657B2Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2019·Granted Dec 27, 2022·0 cites·11 claims
- 0879US2022112260A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2021·Application pending·0 cites
- 0978US11077172B2IL-2 variants for the treatment of psoriasisDELINIA INC·Filed 2017·Granted Aug 3, 2021·1 cites·13 claims
- 1077US11059877B2Multivalent regulatory T cell modulatorsDELINIA INC·Filed 2019·Granted Jul 13, 2021·1 cites·5 claims
- 1176US2021070828A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2020·Application pending·0 cites
- 1271US2021047382A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2020·Application pending·0 cites
- 1367US2019375812A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2019·Application pending·0 cites
- 1465US2021308222A1Il-2 variants for the treatment of autoimmune diseasesDELINIA INC·Filed 2021·Application pending·0 cites
- 1563US2017327555A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2017·Application pending·0 cites
- 1660US2017204154A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2016·Application pending·0 cites
- 1760US2017051029A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2016·Application pending·0 cites
- 1860US2017037102A1Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseasesDELINIA INC·Filed 2016·Application pending·0 cites
- 1948US2021403579A1Multivalent regulatory t cell modulatorsDELINIA INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DELINIA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →